Fibroblast growth factor-21 (FGF-21) is a novel metabolically active hormone that has been investigated, given its potential therapeutic role in obesity and metabolic recovery following bariatric surgery, particularly for diabetes. This evidence concerns the gene FGF21 and obesity disorder.